Abstract:The gut microbiome is composed of a diverse and dynamic community of microorganisms colonizing the intestinal lumen and mucosa. Using germ‐free systems, recent research has established the importance of these communities in influencing key metabolic, endocrine, and immunologic processes in the host. The majority of this research has focused on the effects of the microbiome on the intestine, the tissue with which it is in the most intimate contact. Recent studies, however, have revealed that these effects are significantly more far‐reaching, with roles in hepatic, cardiovascular, and even neurological health. As the primary metabolic and detoxification hub, the liver is a critical checkpoint between the digestive functions of the gut and the rest of the body. Therefore, it is likely that alterations in the gut microbiota affect liver health and homeostasis. To investigate this, we undertook analysis of hepatic metabolite composition using LC MS/MS mass spectrometry. These data demonstrate a significant shift in hepatic metabolism between germ‐free (GF) and conventionalized (CV) mice. Subsequent in‐silico pathway analysis of these altered metabolites suggests alterations in antioxidant and xenobiotic response pathways. A master regulator of these pathways is Nrf2, a basic leucine zipper transcription factor. Indeed, RNAseq analysis of liver tissue revealed a significant induction of Nrf2 target transcripts in CV animals. These data suggest a key role for the microbiome in fine‐tuning host xenobiotic metabolism through activation of Nrf2. We hypothesize that this signaling was mediated by discreet members of the gut microbiome. To identify bacteria capable of inducing hepatic Nrf2, we monocolonized germ‐free drosophila and measured Nrf2 activation in the fat body, an organ analogous to the liver. These data revealed a potent activation of fat body Nrf2 by lactobacilli, particularly Lactobacillus rhamnosus GG (LGG). To extend these findings we next investigated the ability of LGG to augment this pathway in mammals. We performed daily administration of LGG by oral gavage to conventional mice. In these mice we observe increased hepatic Nrf2 activity relative to vehicle control as determined by increased Nrf2 stabilization, nuclear localization, and target transcription. While these findings provide a novel insight into the role of the gut microbiome in influencing signaling pathways in the liver, the functional significance of these findings was still unclear. Given the critical role for Nrf2 in protecting against oxidative liver injury, such as that induced by acetaminophen overdose, we next investigated the role of LGG against acetaminophen challenge. Indeed, in both drosophila and in mice, LGG treatment significantly attenuated morbidity and mortality after acetaminophen overdose in a Nrf2‐dependent manner. These data provide novel mechanistic insight into probiotic mediated impacts on hepatic health. In future studies, we will attempt to identify the bacterial‐produced or induced small molecule mediators of the observed Nrf2 induction and subsequent hepatoprotection.Support or Funding InformationRO1AI64462;F30DK117570This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Protective Effect of Lactobacillus rhamnosus GG and its Supernatant against Myocardial Dysfunction in Obese Mice Exposed to Intermittent Hypoxia is Associated with the Activation of Nrf2 Pathway

Probiotic Lactobacillus Rhamnosus GG Reduces Mortality of Septic Mice by Modulating Gut Microbiota Composition and Metabolic Profiles.

Lactobacillus Rhamnosus Gg Treatment Improves Intestinal Permeability And Modulates Microbiota Dysbiosis In An Experimental Model Of Sepsis

Probiotic Culture Supernatant Improves Metabolic Function Through FGF21-adiponectin Pathway in Mice.

Effect of Lactobacillus rhamnosus GG on Energy Metabolism, Leptin Resistance, and Gut Microbiota in Mice with Diet-Induced Obesity

Protective effect and mechanism of lactoferrin combined with hypoxia against high-fat diet induced obesity and non-alcoholic fatty liver disease in mice

Lactobacillus rhamnosus GG and Oat Beta-Glucan Regulated Fatty Acid Profiles along the Gut-Liver-Brain Axis of Mice Fed with High Fat Diet and Demonstrated Antioxidant and Anti-Inflammatory Potentials

Anti-obesity Effect of Lactobacillus Rhamnosus LS-8 and Lactobacillus Crustorum MN047 on High-Fat and High-Fructose Diet Mice Base on Inflammatory Response Alleviation and Gut Microbiota Regulation

Preventive Effect and Molecular Mechanism of Lactobacillus rhamnosus JL1 on Food-Borne Obesity in Mice

Lacticaseibacillus rhamnosus GG alleviate sleep deprivation induced-intestinal barrier dysfunction and neuroinflammation in mice

Evaluation of a Standard Dietary Regimen Combined with Heat-Inactivated Lactobacillus gasseri HM1, Lactoferrin-Producing HM1, and Their Sonication-Inactivated Variants in the Management of Metabolic Disorders in an Obesity Mouse Model

Recombinant human glucagon-like peptide-1 protects against chronic intermittent hypoxia by improving myocardial energy metabolism and mitochondrial biogenesis

Oral Supplements of Combined Bacillus licheniformis Zhengchangsheng® and Xylooligosaccharides Improve High-Fat Diet-Induced Obesity and Modulate the Gut Microbiota in Rats

[Protective Effects of Antioxidants on Chronic Intermittent Hypoxia-Induced Cardiac Remodeling in Mice].

Cardioprotective Effect of Gossypin Against Myocardial Ischemic/Reperfusion in Rats via Alteration of Oxidative Stress, Inflammation and Gut Microbiota

Effect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese mice

Lactobacillus rhamnosus 069 and Lactobacillus brevis 031: Unraveling Strain-Specific Pathways for Modulating Lipid Metabolism and Attenuating High-Fat-Diet-Induced Obesity in Mice

Lactobacillus johnsonii YH1136 plays a protective role against endogenous pathogenic bacteria induced intestinal dysfunction by reconstructing gut microbiota in mice exposed at high altitude

Lactobacillus rhamnosus GG Colonization in Early Life Ameliorates Inflammaging of Offspring by Activating SIRT1/AMPK/PGC-1α Pathway

Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice

Regulation of the Hepatic Antioxidant Response by the Probiotic Lactobacillus Rhamnosus GG